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INTRODUCTION 
 Peritonitis is defined as inflammation of the serosal membrane that 
lines the abdominal cavity and the organs contained therein. The 
peritoneum, which is an otherwise sterile environment, reacts to a variety 
of pathologic stimuli with a fairly uniform inflammatory response. 
Depending on the underlying pathology, the resultant peritonitis may be 
infectious or sterile (ie, chemical or mechanical). 
Peritonitis is most often caused by introduction of an infection into 
the otherwise sterile peritoneal environment through organ perforation, but 
it may also result from other irritants, such as foreign bodies, bile from a 
perforated gall bladder or a lacerated liver, or gastric acid from a 
perforated ulcer. Women also experience localized peritonitis from an 
infected fallopian tube or a ruptured ovarian cyst. Patients may present 
with an acute or insidious onset of symptoms, limited and mild disease, or 
systemic and severe disease with septic shock. 
 Peritoneal infections are classified as primary (ie, from 
hematogenous dissemination, usually in the setting of 
immunocompromise), secondary (ie, related to a pathologic process in a 
visceral organ, such as perforation, trauma, or postoperative), or tertiary 
(ie, persistent or recurrent infection after adequate initial therapy). 
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 Infections in the peritoneum are further divided into generalized 
(peritonitis) and localized (intra-abdominal abscess). This article focuses 
on the diagnosis and management of infectious peritonitis and abdominal 
abscesses. An abdominal  abscess is seen in the images below. 
Reproducible scoring systems that allow a surgeon to determine the 
severity of the intrabdominal infection are essential to: 1) ratify the  
effectiveness of different treatment regimens, 2) scientifically compare 
surgical intensive care units, 3) help indicate individual risk to select  
patients who may require a more  aggressive surgical approach and 4) be 
able to inform patient´s relatives with greater  objectivity (6). 
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AIM OF STUDY 
 
A study to confirm the predicative value of MPI among patients 
with intraoperative diagnosis of peritonitis at the surgical department , to 
evaluate severity of peritonitis and to make a prognosis of survival-
mortality, considering the risk factors analyzed in this index 
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PATIENTS AND METHODS 
A  prospective, descriptive, transversal and observational study was 
undertaken. Patients  included were all male and female patients, 14 years 
of age or older, seen at the Surgical Service . with diagnosis of peritonitis 
confirmed during surgery regardless of etiology. Once diagnosis of 
peritonitis had been determined by operative findings registered in the 
postoperative report, the patient was accepted into the study. Using data 
recollection sheets, risk factors found in MPI were classified according to 
values indicated in Table I  and individual variable scores were added to 
establish initial MPI score. In addition to personal data such as name, age, 
sex, etc.,the following intrahospital information was registered: file 
number; dates of admission and discharge from the  hospital; days 
hospitalized; date of surgery and information related to illness (surgical  
findings, medical treatment and evolution of illness). Patient evolution was 
followed, indicating  presence of complications and discharge due to 
improvement or death. Time elapsed from initial diagnosis to moment of 
event (death or discharge from hospital) was determined. The minimum 
possible score was zero, if no adverse factor were present, and maximum 
was 47 if presence of all were confirmed. Patients were  divided in three 
groups according to the following categories (MPI points) fewer than 15;  
from 16 to 25, and more than 25. . A life table, using the actuaria method, 
was constructed to compare patient survival with peritonitis severity 
according to MPI score. To determine significance of possible differences 
among three categories (< 15 points, between16 and 25, and >25 points).  
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REVIIEW OF LITERATURE 
 
Untreated, acute peritonitis may be fatal. The fundamental role of 
operative therapy in the treatment of peritonitis was documented in 1926 
when Kirschner reported that the mortality rate from intra-abdominal 
infections decreased from more than 90% to less than 40% during the 
period from 1890-1924 with the introduction of  operative management. 
Other elements, such as advances in the understanding of damage control 
surgery, novel antibiotics, and improvements in intensive care unit (ICU) 
treatment have now reduced mortality to approximately 20%.The current 
approach to peritonitis and peritoneal abscesses targets correction of the 
underlying process, administration of systemic antibiotics, and supportive 
therapy to prevent or limit secondary complications due to organ system 
failure. 
              In 1986, Wacha H et al. published the Mannheim peritonitis index 
(MPI) based on analysis of 17 possible risks factors in patients with 
peritonitis; only eight factors were truly relevant to prognosis (age, sex, 
organ failure, cancer, duration of peritonitis, involvement of colon, 
extension of spread and character of peritoneal fluid) and were finally 
included in the index. The score considers clinic risk factors routinely 
found in preoperative and  transoperative registers(14). This information is 
obtained during first laparotomy to establish an initial classification. Early 
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evaluation of severity of illness using MPI allows us to estimate the 
probability of patient survival(8,15). The MPI is one of the most simple  
scoring systems in use that allows the surgeon to easily determine outcome 
risk during initial surgery. The recollection of retrospective data is possible 
and valid, because MPI only requires information routinely found in 
surgical registers. 
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PERITONITIS AND ABDOMINAL SEPSIS 
Frequency 
The overall incidence of peritoneal infection and abscess is difficult 
to establish and varies with the underlying abdominal disease processes. 
The most common etiology of primary peritonitis is spontaneous bacterial 
peritonitis (SBP) caused by chronic liver disease. Up to 30% of all patients 
with liver cirrhosis with ascites develop SBP.The common etiologic 
entities of secondary peritonitis (SP) include perforated appendicitis; 
perforated gastric or duodenal ulcer; perforated (sigmoid) colon caused by 
diverticulitis, volvulus, or cancer; and strangulation of the small bowel (see 
Table 1). Necrotizing pancreatitis can also be associated with peritonitis in 
the case of infection of the necrotic tissue. The local inflammatory 
response in the study's patients with SP was significantly more severe than 
it was in patients with SBP, and the mortality rate during hospitalization 
was higher for SP than for SBP patients (66% vs 26.4%, respectively). 
However, patients with SP who underwent surgical treatment tended to 
have a lower mortality rate than did those who received only medical 
therapy (53.8% vs 81.8%, respectively). Among the surgically treated 
patients with SP, the survival rate was greater in those with the shortest 
time between diagnostic paracentesis  and surgery (3.2+/-2.4 days in 
survivors vs 7.2+/-6.1 days in nonsurvivors, p=0.31).  
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Table 1. Common Causes of Secondary Peritonitis 
Source Regions Causes 
Esophagus Boerhaave syndrome  
Malignancy 
Trauma (mostly penetrating) 
Iatrogenic* 
Stomach Peptic ulcer perforation 
Malignancy (eg, adenocarcinoma, lymphoma, 
gastrointestinal stromal tumor) 
Trauma (mostly penetrating) 
Iatrogenic* 
Duodenum Peptic ulcer perforation 
Trauma (blunt and penetrating) 
Iatrogenic* 
Biliary tract Cholecystitis  
Stone perforation from gallbladder (ie, gallstone 
ileus) or common duct 
Malignancy 
Choledochal cyst (rare) 
Trauma (mostly penetrating) 
Iatrogenic* 
Pancreas Pancreatitis (eg, alcohol, drugs, gallstones) 
Trauma (blunt and penetrating) 
Iatrogenic* 
Small bowel Ischemic bowel 
Incarcerated hernia (internal and external) 
Closed loop obstruction 
Crohn disease  
Malignancy (rare) 
Meckel diverticulum  
Trauma (mostly penetrating) 
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Large bowel and 
appendix 
Ischemic bowel 
Diverticulitis 
Malignancy 
Ulcerative colitis and Crohn disease 
Appendicitis  
Colonic volvulus 
Trauma (mostly penetrating) 
Iatrogenic 
Uterus, salpinx, 
and ovaries 
Pelvic inflammatory disease (eg, salpingo-oophoritis, 
tubo-ovarian abscess, ovarian cyst) 
Malignancy (rare) 
Trauma (uncommon) 
 
The most common cause of postoperative peritonitis is anastomotic 
leak, with symptoms generally appearing around postoperative days 5-7. 
After elective abdominal operations for noninfectious etiologies, the 
incidence of SP (caused by anastomotic disruption, breakdown of 
enterotomy closures, or inadvertent bowel injury) should be less than 2%. 
Operations for inflammatory disease (ie, appendicitis, diverticulitis, 
cholecystitis) without perforation carry a risk of less than 10% for the 
development of SP and peritoneal abscess. This risk may rise to greater 
than 50% in gangrenous bowel disease and visceral perforation. 
.Peritonitis is also a frequent complication and significant limitation of 
peritoneal dialysis.]Peritonitis leads to increased hospitalization and 
mortality rates.  
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Etiology 
Table 2. Microbiology of Primary, Secondary, and Tertiary Peritonitis 
Peritonitis 
(Type) 
Etiologic 
Organisms Antibiotic Therapy 
(Suggested) 
Class 
Primary Gram-negative Third-generation cephalosporin 
Secondary Gram-negative Second-generation cephalosporin 
Third-generation cephalosporin 
Penicillins with anaerobic activity 
Quinolones with anaerobic activity 
Quinolone and metronidazole 
Aminoglycoside and metronidazole 
Gram-positive 
Anaerobic 
Tertiary Gram-negative Second-generation cephalosporin 
Third-generation cephalosporin 
Penicillins with anaerobic activity 
Quinolones with anaerobic activity 
Quinolone and metronidazole 
Aminoglycoside and metronidazole 
Carbapenems 
Triazoles or amphotericin (considered in 
fungal etiology) 
(Alter therapy based on culture results.) 
Gram-positive 
Fungal 
 
Pathophysiology 
In peritonitis caused by bacteria, the physiologic response is 
determined by several factors, including the virulence of the contaminant, 
the size of the inoculum, the immune status and overall health of the host 
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(eg, APACHE II score), and the elements of the local environment, such as 
necrotic tissue, blood, or bile.Alterations in fibrinolysis (through increased 
plasminogen activator inhibitor activity) and the production of fibrin 
exudates have an important role in peritonitis. The production of fibrin 
exudates is an important part of the host defense, but large numbers of 
bacteria may be sequestered within the fibrin matrix. This may retard 
systemic dissemination of intraperitoneal infection and may decrease early 
mortality rates from sepsis, but it also is integral to the development of 
residual infection and abscess formation. As the fibrin matrix matures, the 
bacteria within are protected from host clearance mechanisms.The ultimate 
effect (containment vs persistent infection) of fibrin may be related to the 
degree of peritoneal bacterial contamination.  
This bacterial load may locally overwhelm the host 
defense.Bacterial virulence factors[3 ]that interfere with phagocytosis and 
with neutrophil mediated bacterial killing mediate the persistence of 
infections and abscess formation. Among these virulence factors are 
capsule formation, facultative anaerobic growth, adhesion capabilities, and 
succinic acid production. Synergy between certain bacterial and fungal 
organisms may also play an important role in impairing the host's defense. 
One such synergy may exist between B fragilis and gram-negative 
bacteria, particularly E coli, where co-inoculation significantly increases 
bacterial proliferation and abscess formation.Enterococci may be important 
in enhancing the severity and persistence of peritoneal infections. .. 
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.Abscess formation occurs when the host defense is unable to eliminate the 
infecting agent and attempts to control the spread of this agent by 
compartmentalization. This process is aided by a combination of factors 
that share a common feature, ie, impairment of phagocytotic killing. 
The role of cytokines in mediation of the body's immune response and 
their role in the development of the systemic inflammatory response 
syndrome (SIRS) and multiple organ failure (MOF) have been a major 
focus of research over the past decade. Comparatively little data exist 
about the magnitude of the intraperitoneal/abscess cytokine response and 
implications for the host. Existing data suggest that bacterial peritonitis is 
associated with an immense intraperitoneal compartmentalized cytokine 
response. Higher levels of certain cytokines (ie, tumor necrosis factor-
alpha [TNF-alpha], interleukin [IL]-6) have been associated with worse 
outcomes, as well as secondary (uncontrolled) activation of the systemic 
inflammatory cascade. 
Presentation 
The diagnosis of peritonitis is clinical. Abdominal pain, which may 
be acute or insidious, is the usual chief complaint. Initially, the pain may 
be dull and poorly localized (visceral peritoneum) and often progresses to 
steady, severe, and more localized pain (parietal peritoneum). If the 
underlying process is not contained, the  
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pain becomes diffuse. In certain disease entities (eg, gastric perforation, 
severe acute pancreatitis, intestinal ischemia), the abdominal pain may be 
generalized from the beginning. Anorexia and nausea are frequent 
symptoms and may precede the development of abdominal pain. Vomiting 
may be due to underlying visceral organ pathology (ie, obstruction) or be 
secondary to peritoneal irritation. On physical examination, patients with 
peritonitis generally appear unwell and in acute distress. Many of them 
have a temperature that exceeds 38° C, although patients with severe sepsis 
may become hypothermic. Tachycardia is caused by the release of 
inflammatory mediators, intravascular hypovolemia from anorexia 
vomiting and fever, and third-space losses into the peritoneal cavity. With 
progressive dehydration, patients may become hypotensive, as well as 
oliguric or anuric; with severe peritonitis, they may present in overt septic 
shock. On abdominal examination, almost all patients demonstrate 
tenderness to palpation. In most patients (even with generalized peritonitis 
and severe diffuse abdominal pain), the point of maximal tenderness or 
referred rebound tenderness roughly overlies the pathologic process (ie, the 
site of maximal peritoneal irritation). 
Most patients demonstrate increased abdominal wall rigidity. The 
increase in abdominal wall muscular tone may be voluntary in response to 
or in anticipation of the abdominal examination or involuntary because of 
the peritoneal irritation.  
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Patients with severe peritonitis often avoid all motion and keep their 
hips flexed to relieve the abdominal wall tension. The abdomen is often 
distended, with hypoactive-to-absent bowel sounds. This finding reflects a 
generalized ileus and may not be present if the infection is well localized. 
Occasionally, the abdominal examination reveals an inflammatory mass. 
Rectal examination often elicits increased abdominal pain, particularly 
with inflammation of the pelvic organs, but rarely indicates a specific 
diagnosis. A tender inflammatory mass toward the right may indicate 
appendicitis, and anterior fullness and fluctuation may indicate a cul de sac 
abscess. In female patients, vaginal and bimanual examination findings 
may be consistent with pelvic inflammatory disease (eg, endometritis, 
salpingo-oophoritis, tubo-ovarian abscess), but exam findings are often 
difficult to interpret in severe peritonitis. 
Indications 
Early control of the septic source is mandatory and can be achieved 
by operative and nonoperative means. Operative management addresses 
the need to control the infectious source and to purge bacteria and toxins. 
The type and extent of surgery depends on the underlying disease process 
and the severity of intra-abdominal infection.  Nonoperative interventions 
include percutaneous abscess drainage, as well as percutaneous and 
endoscopic stent placements. If an abscess is accessible for percutaneous 
drainage and if the underlying visceral organ pathology does not clearly 
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require operative intervention, percutaneous drainage is a safe and 
effective initial treatment approach. 
Relevant Anatomy 
The peritoneum is the largest and most complex serous membrane in 
the body. It forms a closed sac (ie, coelom) by lining the interior surfaces 
of the abdominal wall (anterior and lateral), by forming the boundary to 
the retroperitoneum (posterior), by covering the extraperitoneal structures 
in the pelvis (inferior), and by covering the undersurface of the diaphragm 
(superior). This parietal layer of the peritoneum reflects onto the 
abdominal visceral organs to form the visceral peritoneum. It thereby 
creates a potential space between the 2 layers (ie, the peritoneal cavity).  
The peritoneum consists of a single layer of flattened mesothelial 
cells over loose areolar tissue. The loose connective tissue layer contains a 
rich network of vascular and lymphatic capillaries, nerve endings, and 
immune-competent cells, particularly lymphocytes and macrophages. The 
peritoneal surface cells are joined by  junctional complexes, thus forming a 
dialyzing membrane that allows passage of fluid and certain small solutes. 
Pinocytotic activity of the mesothelial cells and phagocytosis by 
macrophages allow for clearance of macromolecules.Normally, the amount 
of peritoneal fluid present is less than 50 mL, and only small volumes are 
transferred across the considerable surface area in a steady state each day. 
The peritoneal fluid represents a plasma ultrafiltrate, with electrolyte and 
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solute concentrations similar to that of neighboring interstitial spaces and a 
protein content of less than 30 g/L, mainly albumin. In addition, peritoneal 
fluid contains small numbers of desquamated mesothelial cells and various 
numbers and morphologies of migrating immune cells (reference range is 
<300 cells/µL, predominantly of mononuclear morphology)The peritoneal 
cavity is divided incompletely into compartments by the mesenteric 
attachments and secondary retroperitonealization of certain visceral 
organs. A large peritoneal fold, the greater omentum, extends from the 
greater curvature of the stomach and the inferior aspect of the proximal 
duodenum downward over a variable distance to fold upon itself (with 
fusion of the adjacent layers) and ascends back to the taenia omentalis of 
the transverse colon. This peritoneal fold demonstrates a slightly different 
microscopic anatomy, with fenestrated surface epithelium and a large 
number of adipocytes, lymphocytes, and macrophages, and it functions as 
a fat storage location and a mobile immune organ. The 
compartmentalization of the peritoneal cavity, in conjunction with the 
greater omentum, influences the localization and spread of peritoneal 
inflammation and infections. 
Workup 
Laboratory Studies 
 CBC with differential - Most patients will have leukocytosis 
(>11,000 cells/µL),  
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 Blood chemistry - May reveal dehydration and acidosis  
 PT, PTT, and INR  
 Liver function tests - If clinically indicated  
 Amylase and lipase - If pancreatitis is suspected  
 Urinalysis (UA) - To rule out urinary tract diseases (eg, 
pyelonephritis, renal stone disease); however, patients with lower 
abdominal and pelvic infections often demonstrate WBCs in the 
urine and microhematuria.  
 Stool sample - In patients with diarrhea, evaluate a stool sample — 
employing a Clostridium difficile toxin assay, a WBC count, and a 
specific culture (ie, Salmonella, Shigella, cytomegalovirus [CMV]) 
— if the patient's history suggests infectious enterocolitis.  
 Aerobic and anaerobic blood cultures  
 Peritoneal fluid (ie, paracentesis, aspiration of abdominal fluid 
collections, intraoperative peritoneal fluid cultures)  
o Diagnostic peritoneal lavage (DPL) may be helpful in patients 
who do not have conclusive signs on physical examination or 
who cannot provide an adequate history. A DPL with more 
than 500 leukocytes/mL is considered positive and suggests 
peritonitis.  
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o Evaluate the sample for pH, glucose, protein, lactate 
dehydrogenase (LDH), cell count, Gram stain, and aerobic 
and anaerobic cultures.  
o Include analysis if pancreatitis or pancreatic leak is suspected.  
o Test for bilirubin when a biliary leak is suspected and for fluid 
creatinine level when a urinary leak is suspected.  
o Compare the peritoneal levels to the respective serum level 
Imaging Studies 
 Radiographs  
o Plain films of the abdomen (eg, supine, upright, and lateral 
decubitus positions) are often the first imaging studies 
obtained in patients presenting with peritonitis. Their value in 
reaching a specific diagnosis is limited.  
o Free air is present in most cases of anterior gastric and 
duodenal perforation but is much less frequent with 
perforations of the small bowel and colon and is unusual with 
appendiceal perforation. .. 
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MULTPLE AIR FLUID LEVELS I N INTESTINAL 
OBSTRUCTION 
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COFFEE BEAN APPEARENCE IN SIGMOID VOLVULUS  
 Ultrasonography  
o Abdominal ultrasonography may be helpful in the evaluation 
of right upper quadrant (eg, perihepatic abscess, cholecystitis, 
biloma, pancreatitis, pancreatic pseudocyst), right lower 
quadrant, and pelvic pathology (eg, appendicitis, tubo-ovarian 
abscess, Douglas pouch abscess), but the examination is 
sometimes limited because of patient discomfort, abdominal 
distension, and bowel gas interference.  
o Ultrasonography may detect increased amounts of peritoneal 
fluid (ascites), but its ability to detect quantities of less than 
100 mL is limited. . 
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o Ultrasonographically guided aspiration and placement of 
drains has evolved into a valuable tool in the diagnosis and 
treatment of abdominal fluid collections (see Medical 
Therapy). 
 CT scanning  
o If the diagnosis of peritonitis is made clinically, a CT scan is 
not necessary and generally delays surgical intervention 
without offering clinical advantage. CT scans of the abdomen 
and pelvis remain the diagnostic study of choice for peritoneal 
abscess and related visceral pathology. CT scanning is 
indicated in all cases in which the diagnosis cannot be 
established on clinical grounds and findings on abdominal 
plain films. Whenever possible, the CT scan should be 
performed with enteral and intravenous contrast. CT scans can 
detect small quantities of fluid, areas of inflammation, and 
other GI tract pathology, with sensitivities that approach 
100%.   
o Peritoneal abscesses and other fluid collections may be 
aspirated for diagnosis and drained under CT guidance; this 
technique has become a mainstay of therapy (see Medical 
Therapy). 
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MULTIPLE AIR FLUID LEVELS IN CT 
o Nuclear medicine scans  
o .. They are most frequently used in the evaluation of fever of 
unknown origin or in patients with persistent fever despite 
adequate antibiotic treatment and negative CT scan findings. 
 Magnetic resonance imaging (MRI)  
o MRI is an emerging imaging modality for the diagnosis of 
suspected intra-abdominal abscesses. . 
 Contrast studies  
o Conventional contrast studies (ie, Gastrografin swallow, 
upper GI tract study with follow-through, colorectal contrast 
enema, fistulogram, contrast studies of drains and stents) are 
reserved for specific indications in the setting of suspected 
peritonitis or peritoneal abscess. 
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Diagnostic Procedures 
 See Surgical Therapy for a discussion of laparoscopy. 
Treatment 
Medical Therapy 
The general principles guiding the treatment of intra-abdominal 
infections are 4-fold: (1) to control the infectious source, (2) to eliminate 
bacteria and toxins, (3) to maintain organ system function, and (4) to 
control the inflammatory process. The treatment of peritonitis is 
multidisciplinary, with complimentary application of medical, operative 
and nonoperative interventions included in the therapy. Medical support 
includes (1) systemic antibiotic therapy; (2) intensive care with 
hemodynamic, pulmonary, and renal support; (3) nutrition and metabolic 
support; and (4) inflammatory response modulation therapy. 
Early control of the septic source is mandatory and can be achieved by 
operative and nonoperative means. Nonoperative interventional therapies 
include percutaneous drainage of abscesses and percutaneous and 
endoscopic stent placements. Treatment of peritonitis and intra-abdominal 
sepsis always begins with volume resuscitation, correction of potential 
electrolyte and coagulation abnormalities, and empiric broad-spectrum 
parenteral antibiotic coverage.  
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Antibiotic therapy 
Spontaneous bacterial peritonitis 
Untreated SBP has a mortality rate of up to 50%, but with prompt 
diagnosis and treatment of the condition, this figure may be reduced to 
20%. Empiric therapy with a third-generation cephalosporin must begin 
promptly and can subsequently be narrowed according to the culture 
results. Avoid aminoglycosides in patients with liver disease, because 
these patients are at an increased risk for nephrotoxicity.  
The optimal duration of therapy is not known; traditionally, a course 
of 10 days is recommended, although studies have suggested that 5 days of 
therapy (with documentation of a decrease of peritoneal fluid WBC count 
to <250 cells/μ L) may be sufficient in most cases. 
Secondary and tertiary peritonitis 
In secondary and tertiary peritonitis, systemic antibiotic therapy is 
the second mainstay of treatment.[6 ]Several studies suggest that antibiotic 
therapy is not as effective in the infection's later stages and that early 
(preoperative) systemic antibiotic therapy can significantly reduce the 
concentration and growth rates of viable bacteria in the peritoneal fluid. 
Antibiotic therapy begins with empiric coverage (effective against 
common gram negative and anaerobic pathogens) and should be initiated 
as soon as possible, with a transition made to narrower spectrum agents as 
culture results become available. 
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Perforations of upper GI tract organs are associated with gram-positive 
bacteria, whereas the distal small bowel and colon perforations involve 
polymicrobial aerobic and anaerobic species. Most studies suggest that 
single-drug therapy is as effective as dual or triple combination therapy in 
mild to moderate abdominal infections.In severe and hospital-acquired 
intra-abdominal infections, imipenem, piperacillin/tazobactam, and a 
combination of aminoglycosides and metronidazole are often effective. 
The optimal duration of antibiotic therapy must be individualized 
and depends on the underlying pathology, severity of infection, speed and 
effectiveness of source control, and patient response to therapy. In 
uncomplicated peritonitis in which there is early, adequate source control, 
a course of 5-7 days of antibiotic therapy is adequate in most cases. Mild 
cases (eg, early appendicitis, cholecystitis) may not need more than 24-72 
hours of postoperative therapy. Inadequate initial therapy has been linked 
to worse outcomes, and these outcomes could not be significantly changed 
by later specific or prolonged therapy. Antimicrobial therapy should 
continue until signs of infection (eg, fever, leukocytosis) have resolved; 
when signs of infection continue, persistent infection or the presence of a 
nosocomial infection should be investigated. 
Some patients demonstrate persistent signs of inflammation without 
a defined infectious focus. In these patients, continued broad-spectrum 
antibiotic therapy may be more harmful than beneficial (eg, emergence of 
resistant organisms, C difficile colitis), and a trial of antibiotic therapy 
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cessation under close surveillance may be warranted.Of note, antibiotics 
alone are seldom sufficient to treat intra-abdominal abscesses, and 
adequate drainage of the abscess is of paramount importance. For most of 
the commonly used antibiotics, abscess fluid antibiotic levels are generally 
below the minimum inhibitory concentration-90 (MIC90) for B fragilis 
and E coli, and repeated dosing or high-dose therapy does not improve 
penetration significantly. 
Nonoperative drainage 
CT scan – and ultrasonographically guided percutaneous drainage 
are well established as effective source controls and may in some cases 
decrease the need for surgical therapy. In some instances, success also 
includes the ability to delay surgery until the acute process and sepsis are 
resolved and a definitive procedure can be performed under elective 
circumstances. 
Percutaneous and surgical drainage should not be considered 
competitive but rather complementary. If an abscess is accessible to 
percutaneous drainage and the underlying visceral organ pathology does 
not clearly require an operative approach, percutaneous drainage can be 
used safely and effectively as the primary treatment modality. In these 
cases, patients must be closely monitored, and improvement should be 
observed in less than 24-48 hours. With lack of improvement, patients 
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must be reevaluated aggressively (eg, repeat CT scan) and the therapeutic 
strategy should be altered accordingly. 
Surgical Therapy 
Surgery remains a cornerstone of treating peritonitis. Any operation 
should address the first 2 principles of the treatment of intra-peritoneal 
infections: early and definitive source control and elimination of bacteria 
and toxins from the abdominal cavity. The issue of timing and adequacy of 
surgical source control is paramount because an improper, untimely, or 
incorrect operation may have an overwhelmingly negative effect on 
outcome (compared to medical therapy). 
The operative approach is directed by the underlying disease process 
and the type and severity of the intra-abdominal infection. In many cases, 
the indication for operative intervention will be clear, as in cases of 
peritonitis caused by ischemic colitis, a ruptured appendix, or colonic 
diverticula. The surgeon should always strive to arrive at a specific 
diagnosis and delineate the intra-abdominal anatomy as accurately as 
possible prior to the operation. 
However, in severe abdominal sepsis, delays in operative 
management may lead to a significantly higher need for reoperations and 
to worse outcomes overall; early exploration (ie, prior to completion of 
diagnostic studies) may be indicated. Surgical intervention may include 
resection of a perforated viscus with re-anastomosis or creation of a fistula. 
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To reduce the bacterial load, a lavage of the abdominal cavity is 
performed, with particular attention to areas prone to abscess formation 
(e.g., paracolic gutters, subphrenic area). 
These patients may best be served by a period of 12-24 hours of 
observation and intensive medical support. Deterioration of the patient's 
clinical status or development of organ-specific indications (eg, intra-
abdominal bleed, gas-forming infection of the pancreas) should lead to 
prompt operation. Percutaneous treatment is reserved for the management 
of defined peripancreatic fluid collections in stable patients. Pancreatic 
abscess or infected pancreatic necrosis generally should be treated with 
surgical debridement and repeated exploration. If an anastomotic 
dehiscence is suspected, percutaneous drainage is of limited value, and the 
patient should be treated surgically. 
Open-abdomen technique and scheduled reoperation  
In certain situations, staging the operative approach to 
intraperitoneal infections is appropriate. Staging may be performed as a 
scheduled second-look operation or through open management, with or 
without temporary closure (eg, mesh, VAC technique). 
Second-look operations may be used in a damage control fashion. In 
these cases, the patient at initial operation is severely ill and unstable from 
septic shock or coagulopathy (eg, mediator liberation, disseminated 
intravascular coagulation). The goal of the initial operation is to provide 
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preliminary drainage and to remove obviously necrotic tissue. Then, the 
patient is resuscitated and stabilized in an ICU setting for 24-36 hours and 
returned to the operating room for a more definitive drainage and source 
control. 
In conditions related to bowel ischemia, the initial operation aims to 
remove all frankly devitalized bowel. The second-look operation serves to 
reevaluate for further demarcation and decision-making regarding 
reanastomosis or diversion.In severe peritonitis, particularly with extensive 
retroperitoneal involvement (eg, necrotizing pancreatitis), open treatment 
with repeat reexploration, debridement, and intraperitoneal lavage has been 
shown to be effective. 
Laparoscopy 
Laparoscopy is gaining wider acceptance in the diagnosis and 
treatment of abdominal infections. As with all indications for laparoscopic 
surgery, outcomes vary depending on the skill and experience of the 
laparoscopic surgeon. 
Initial laparoscopic examination of the abdomen can assist in 
determination of the etiology of peritonitis (eg, right lower quadrant 
pathology in female patients). Laparoscopic surgery is commonly used in 
the treatment of uncomplicated appendicitis, although in preliminary 
studies, outcomes for complicated appendicitis have generally been 
positive. For complicated and uncomplicated appendicitis, the laparoscopic 
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approach is associated with a shorter length of stay and fewer wound 
infections than the open approach; however laparoscopic surgery may be 
associated with a higher rate of intra-abdominal abscess. 
Laparoscopic diagnosis and peritoneal lavage in patients with 
peritonitis secondary to diverticulitis has been shown to be safe and has 
helped to avoid the need for colostomy in many patients in small clinical 
trials. Successful laparoscopic repair of perforated gastric and duodenal 
ulcers has also been reported. 
The treatment of perihepatic infections via laparoscopic approach 
has been well established in acute cholecystitis, where laparoscopic 
cholecystectomy has become the mainstay of therapy. More recently, 
primary treatment of subphrenic abscesses and laparoscopic, 
ultrasonographically assisted drainage of pyogenic liver abscesses have 
been performed successfully. 
Individual reports also describe successful drainage of 
peripancreatic fluid collections and complicated intra-abdominal abscesses 
that are not amenable to  CT scan – or ultrasonographically guided 
percutaneous drainage. 
As minimally invasive procedures continue to advance 
technologically, use of these approaches is likely to increase, reducing the 
need for the open surgical approach for peritoneal abscess drainage.  
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Preoperative Details: 
Volume resuscitation and prevention of secondary organ system 
dysfunction are of utmost importance in the treatment of patients with 
intra-abdominal infections. Depending on the severity of the disease, these 
patients should have Foley catheters placed to monitor urine output. Use 
invasive hemodynamic monitoring in  severely ill patients to guide volume 
resuscitation and inotropic support. Correct existing serum electrolyte 
disturbances and coagulation abnormalities as best as possible before any 
intervention. Begin empiric broad-spectrum systemic antibiotic therapy as 
soon as the diagnosis of intra-abdominal infection is suspected and tailor 
therapy according to the underlying disease process and culture results. 
Remember that patients with peritonitis often have severe abdominal pain. 
Provide adequate analgesia with parenteral narcotic agents as soon as 
possible. In the setting of significant nausea, vomiting, or abdominal 
distension caused by obstruction or ileus, institute nasogastric 
decompression as soon as possible. Consider intubation and ventilator 
support early in patients with evidence of septic shock or altered mental 
status to prevent further decompensation. 
Even if patients do not appear critically ill initially, arranging for 
postoperative intensive care support before the operation is often wise, 
particularly in patients of advanced age and those with significant 
comorbidities.In patients with severe infections and certain disease 
processes (eg, necrotizing pancreatitis, bowel ischemia), informed consent 
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should include the potential need for several reoperations and enteric 
diversion. The involved physicians and surgeon should not downplay the 
significant morbidities associated with abdominal sepsis when discussing 
these issues with the patient and/or family. 
Intraoperative Details 
 The goals of operative treatment of peritonitis are to eliminate the 
source of contamination, to reduce the bacterial inoculum, and to prevent 
recurrent or persistent sepsis. A vertical midline incision is the incision of 
choice in most patients with generalized peritonitis because it allows 
access to the entire peritoneal cavity. In patients with localized peritonitis 
(eg, acute appendicitis, cholecystitis), an incision directly over the site of 
pathology (eg, right lower quadrant, right subcostal) is usually adequate. In 
patients with an unclear etiology of the peritonitis, initial diagnostic 
laparoscopy may be useful.The intra-abdominal anatomy may be 
significantly distorted because of inflammatory masses and adhesions. 
Normal tissue planes and boundaries may be obliterated. The inflamed 
organs are often very friable, and the surgeon must exercise great caution 
when exploring the patient with peritoneal infection.Hemodynamic 
instability may occur at any time during treatment because of bacteremia 
and cytokine release. Patients often demonstrate significant fluid shifts 
with third spacing. Swelling of the bowel, retroperitoneum, and abdominal 
wall may preclude safe abdominal closure after prolonged cases in patients 
who are severely ill.Inflammation causes regional hyperemia, and sepsis 
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may cause coagulation deficits and platelet dysfunction, leading to 
increased bleeding. Careful dissection and meticulous hemostasis are of 
utmost importance. 
When faced with extensive abdominal inflammatory disease and 
septic shock, draining the infection temporarily, controlling the visceral 
leak quickly (eg, oversewing, enteric diversion), and deferring any 
definitive repair until after the patient has recovered from the initial insult 
(ie, damage control operation) may be better.One of the critical decisions 
in the surgical treatment of patients with severe peritonitis is regarding 
whether to use a closed-abdomen or open-abdomen technique. The goal of 
the closed-abdomen technique is to provide definitive surgical treatment at 
the initial operation; perform primary fascial closure and perform repeat 
laparotomy only when clinically indicated. The goal of the open-abdomen 
technique is to provide easy direct access to the affected area. Source 
control is achieved through repeated reoperations or open packing of the 
abdomen. This technique may be well suited for initial damage control in 
extensive peritonitis.Also consider patients who are at high risk for 
development of abdominal compartment syndrome (eg, intestinal 
distension, extensive abdominal wall and intra-abdominal organ edema) 
for this technique because attempts to perform primary fascial closure 
under significant tension in these circumstances are associated with an 
increased incidence of MOF (eg, renal, respiratory), necrotizing abdominal 
wall infections, and mortality. 
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Postoperative Details 
Postoperatively, monitor all patients closely in the appropriate 
clinical setting for adequacy of volume resuscitation, resolution or 
persistence of sepsis, and the development of organ system failure. 
Appropriate systemic broad-spectrum antibiotic coverage must be 
continued without interruption for the appropriate time (see Medical 
Therapy). The patient's overall condition should improve significantly and 
progressively within 24-72 hours of the initial treatment (ie, resolution of 
the signs and symptoms of infection, mobilization of interstitial fluid). This 
time course may be prolonged in patients who are critically ill with 
significant multiple organ system dysfunction. A lack of improvement 
should prompt an aggressive search for a persistent or recurrent 
intraperitoneal or new extraperitoneal infectious focus.Patients requiring 
surgical intervention for peritonitis demonstrate a significantly increased 
risk for surgical site infections and wound healing failure; monitor patients 
closely for this potential complication. All patients who are critically ill 
and patients receiving prolonged antibiotic therapy are at increased risk for 
developing secondary opportunistic infections (eg, C difficile colitis, 
fungal infections, central venous catheter infections, ventilator-associated 
pneumonia); monitor patients closely for signs and symptoms of these 
complications. 
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Nutrition 
In general, patients with peritonitis develop some degree of gut 
dysfunction (eg, ileus) after exploration. Consider establishing some form 
of nutritional support early in the course of treatment because most 
patients have an insufficient enteral intake for a variable amount of time 
preoperatively. The existing data support that enteral nutrition is superior 
to parenteral hyperalimentation. If enteral feeding is contraindicated or not 
tolerated, parenteral nutrition should be instituted. 
Follow-up 
After resolution of peritonitis and peritoneal abscesses, follow-up 
care is directed mostly by specifics of the underlying disease process and 
the presence or absence of chronic complications (eg, enterocutaneous 
fistulae). Patients with simple peritoneal infections after appendicitis or 
cholecystitis are usually cured and do not require long-term follow-up 
care. Patients with peritoneal operations for perforated peptic ulcer disease, 
Crohn disease, pancreatitis, and others often require lifelong medical 
therapy and treatment of recurrent complications. 
Complications 
Surgical site infection/dehiscence 
The incidence of surgical site infection increases with the degree of 
contamination; therefore, surgical site infection occurs at much higher 
rates after operations for peritonitis and peritoneal abscess (ie, 5-15% 
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compared to <5% for elective abdominal operations for noninfectious 
etiologies). Surgical site infection may be expected if the wound is closed 
in the setting of gross abdominal contamination Perioperative systemic 
antibiotics, the use of wound protector devices, and lavage of the wound at 
the end of therapy do not reliably prevent this complication. These wounds 
should be left open and be treated with wet-to-dry dressing changes several 
times a day or VAC dressing should be applied. 
Impaired wound healing 
Complications related to percutaneous drainage 
Percutaneous drainage procedures carry a risk of related significant 
complications of less than 10% (range 5-27%) depending on the 
underlying pathology and abscess location. These complications include 
bleeding, injury, erosion, transgression of small and large bowel, fistula 
formation, and others. Strategies to prevent these problems include 
correction of coagulation problems and determination of the exact 
etiology, location, and anatomic relationships of the abscess. Indication for 
percutaneous treatment of complex abscesses and patients with a persistent 
enteric leak should be reviewed critically, and operative treatment should 
not be delayed with lack of adequate patient improvement. 
Tertiary peritonitis 
Persistence of intra-abdominal infection (ie, tertiary peritonitis) is a 
complication that may occur following the treatment of primary or 
secondary peritonitis and peritoneal abscess.. 
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Complications related to the open-abdomen technique 
        One of the complications related to treatment of severe intra-
abdominal infections with the open-abdomen technique and multiple 
reoperations is the development of enterocutaneous fistulae. . 
         High-output and proximal fistulae often require a delayed surgical 
repair. Optimal timing of this repair is critical. Initial inflammatory 
adhesions and dense scar formation may make safe reexploration 
impossible. Maturation of the scar tissue occurs over 6-12 months. Close 
observation of the patient's overall condition and nutritional status is 
important during that time. Deterioration of the patient's condition may 
force an earlier reoperation. 
Complications related to abdominal compartment syndrome 
ACS is a well-recognized disease entity related to acutely increased 
abdominal pressure (ie, intra-abdominal hypertension [IAH]) and is 
associated with the development of multiple organ dysfunction. 
Complications related to enteric insufficiency 
Extensive initial (gastrointestinal) disease, chronic recurrent 
infections, and associated reoperations may lead to enteric insufficiency 
because of short gut, pancreatic insufficiency, or hepatic dysfunction. 
Treatment of these problems can be quite challenging and can require a 
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multispecialty approach to optimize gastrointestinal function and 
nutritional status. 
Outcome and Prognosis 
Spontaneous bacterial peritonitis 
The overall mortality rate of patients with SBP may exceed 30% if 
diagnosis and treatment are delayed, but the mortality rate is less than 10% 
in fairly well-compensated patients with early therapy. As many as 70% of 
patients who survive an episode of SBP have a recurrent episode within 1 
year, and, for these patients, the mortality rate approaches 50%. Some 
studies suggest that the recurrence rate of SBP may be decreased to less 
than 20% with long-term antibiotic prophylaxis (eg, quinolones, 
trimethoprim-sulfamethoxazole); however, whether this improves long-
term survival without liver transplantation is unclear. 
Secondary peritonitis and peritoneal abscess 
Treatment success of peritoneal infections is defined as adequate 
source control with resolution of sepsis and clearance of all residual intra-
abdominal infection. With percutaneous treatment, the definition of 
success includes the avoidance of further operative intervention and, in 
some cases, the delay of surgery until after resolution of the initial sepsis. 
Over the past decade, the combination of better antibiotic therapy, more 
aggressive intensive care, and earlier diagnosis and therapy with a 
combination of operative and percutaneous techniques have led to a 
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significant reduction in morbidity and mortality related to intra-abdominal 
sepsis.Uncomplicated SP and simple abscesses carry a mortality rate of 
less than 5%, but this rate may increase to greater than 30-50% in severe 
infections. The overall mortality rate related to intra-abdominal abscess 
formation is less than 10-20%. Factors that independently predict worse 
outcomes include advanced age, malnutrition, presence of cancer, a high 
APACHE II score on presentation, preoperative organ dysfunction, the 
presence of complex abscesses, and failure to improve in less than 24-72 
hours after adequate therapy. 
In severe intra-abdominal infections and peritonitis, the mortality 
rate may increase to greater than 30-50%. The concurrent development of 
sepsis, SIRS, and MOF can increase the mortality rate to greater than 70%, 
and, in these patients, more than 80% of deaths occur with an active 
infection present.Several scoring systems (eg, APACHE II, SIRS, multiple 
organ dysfunction syndrome [MODS], Mannheim peritonitis index) have 
been developed to assess the clinical prognosis of patients with peritonitis. 
Most of these scores rely on certain host criteria, systemic signs of sepsis, 
and complications related to organ failure. Although valuable for 
comparing patient cohorts and institutions, these scores have limited value 
in the specific day-to-day clinical decision-making process for any given 
patient. In general, the mortality rate is less than 5% with an APACHE II 
of less than 15 and rises to greater than 40% with scores above 15. Rising 
APACHE II scores on days 3 and 7 are associated with an increase of 
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mortality rates to greater than 90%, whereas falling scores predict 
mortality rates of less than 20%. 
The mortality rate without organ failure generally is less than 5% 
but may rise to greater than 90% with quadruple organ failure. A delay of 
more than 2-4 days of either medical therapy or surgical therapy has been 
clearly associated with increased complication rates, the development of 
tertiary peritonitis, the need for reoperation, multiple organ system 
dysfunction, and death. 
Outcomes are worse in patients requiring emergent reoperations for 
persistent or recurrent infections (30-50% increase in the mortality rate); 
however, patients undergoing early planned second-look operations do not 
demonstrate this trend. 
Persistent infection, recovery of enterococci, and multidrug-resistant 
gram-negative organisms, as well as fungal infection, are related to worse 
outcomes and recurrent complications. 
Patients older than 65 years have a 3-fold increased risk of 
developing generalized peritonitis and sepsis from gangrenous or 
perforated appendicitis and perforated diverticulitis than younger patients 
and are 3 times more likely to die from these disease processes. Older 
patients with perforated diverticulitis are 3 times more likely than younger 
patients to have generalized rather than localized (ie, pericolic, pelvic) 
peritonitis. These findings are consistent with the hypothesis that the 
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biologic features of peritonitis differ in elderly persons, who are more 
likely to present with an advanced or more severe process than younger 
patients with peritonitis. 
Overall, studies suggest that host-related factors are more significant 
than the type and source of infection with regard to the prognosis in intra-
abdominal infections. 
Table 1  Mannheim Peritonitis Index Scoring 
Risk Factor Weighting if present 
Age>50 Years 5 
Female sex 5 
Organ failure 
 
7 
Mailignancy 
 
4 
Preoperative duration of 
peritonitis>24hrs 
4 
Origin of sepsis not colonic 4 
Diffuse generalized peritonitis 6 
Exudate 
Clear 
Cloudy, Purulent 
Fecal 
 
0 
6 
12 
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Future and Controversies 
Laparoscopy is gaining wider acceptance in the diagnosis and 
treatment of abdominal infections (see Laparoscopy in Surgical Therapy). 
However, no definitive guidelines have been established regarding the 
optimal selection of patients for successful laparoscopic repair. As 
minimally invasive procedures continue to advance technologically, use of 
these approaches is likely to increase, reducing the need for the open 
surgical approach for peritoneal abscess drainage. 
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RESULTS 
 
From Jan 2009 to Nov 30 2010  of about  150  patients with 
peritonitis confirmed during surgical intervention were admitted to the 
Surgical Service,except one patient treated conservatively by bilateral 
flank drain due to Ca cervix on radiotherapy. 
Study Group General Data 
Of the sample of 150  patients, 28 were female (18.7%) and 122were 
male (81.3%). Group mean age was 41.8  years with a median of 40  years 
and a range from 14  years and above. Mean age of survivors was 39.78 
years of age ( ± 13.8); among non-survivors, mean age was 53 years ( ± 
11.3) (p <0.0001).    
Of the 150  patients 149  were operated and one was bilateral flank 
drain ,  23(15.3%) died (global mortality 6%),17 (11.4%) were wound 
sepsis and 110(73.3%) were discharged without complication. Origin of 
peritonitis was from more than 6  different anatomic sites and was due to 
various causes (Table   Chart-1.1-1.3).  
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Table .  Peritonitis  assigned to Anatomical location 
 Died Discharged Wound sepsis & Discharged Total 
Duodenal 
Perforation 7 (8%) 67 (81%) 9 (11%) 83 
Gastric 
Perforation 6 (38%) 7 (44%) 3 (18%) 16 
Appendicular 
Pathology 1 (7%) 12 (80%) 2 (13%) 15 
Small bowel 5 (26%) 13 (68%) 1 (6%) 19 
Large Bowel 2 (29%) 5 (71%) 0 7 
Miscellaneous 2 (20%) 6 (60%) 2 (20%) 10 
 
Mannheim Criteria Data 
Group mean MPI score was 18 points. Among surviving patients, 
mean score was 16 points and among non-survivors, mean was 27 points 
(p <0.0001). We can observe the study group life table. survival curves of 
the three subgroups (<15 , 16–25 and >25) have differences that are 
statistically significant. succinctly, break down information of each risk 
factor according to the following  categories: a) MPI scores<15, 16–25 and 
>25,  Results of Odds ratio  for each risk factor, for age over 50 years is 
5.346 and Gender  is  0.(Chart-2.1 to 5.1) 
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DISCUSSION AND CONCLUSION 
 
A glance at the life chart shows a difference in prognosis of the three 
established intervals. There is 1%of deaths in patients with scores <15 MPI 
points, and survival of patients with interval of 15–25 points was superior 
to those with 25 points, confirming the predictive value of MPI among 
patients with surgically diagnosed peritonitis . This implies that survival 
differences observed among three intervals (<15, 16–25, and >25 MPI 
points) are statistically significant(p = <0.001). Mean MPI score of all 
patients with peritonitis studied was 18 points. Among patients who died, 
mean was 27 points compared to 16 points among survivors. This 
difference is statistically significant (p = <0.0001).  Other foreign studies 
show mean MPI scores between 19 and 34 points (range 
0to47points)(6,15,18,21,39,42-45). MPI among survivors and non-
survivors reported is 25 and 31 MPI points, respectively(46). In our study, 
overall mortality rate was 15.3%; other studies report global mortality rates 
from 3.9% to  54% (6,14,15,18,20,21,23,26,32,34, 42,43, 45,47,53). 
In concordance with the life table, when MPI score increased, 
mortality increased, which coincides with other publications.49 .MPI is an 
important index for predicting patient outcome in  peritonitis(54). 
Variouspublications use more than one score study group outcome in 
patients with peritonitis, surgically In the Mexican study previously cited, 
was concluded that the only prognostic factor with statistic value was MPI 
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score in patients with abdominal sepsis; however,  combined with 
APACHE II, prognosis was more thorough, realistic, and significant(47).  
Others differ, concluding that sensitivity and specificity with MPI is 
greater than that calculated with APACHE II(37). When comparing risk 
factors of each variable indicating the presence or absence of adverse 
factor among survivors and non-survivors, a mirror image is expected, as 
occurred. This means that adverse factor is low and favorable factor is high 
in survivors, and the contrary in non-survivors When considering each risk 
factor, constructing a contingency table in which presence or absence of 
adverse factor and result (death or survival) are considered, OR value 
obtained allows us to weigh, each risk factor as follows: presence of 
malignancy; age 50 years; generalized peritonitis; presence of fecal 
peritoneal fluid, and female gender. Contrary to what was expected, in this 
study colonic origin was not an adverse factor. Even though mortality rate 
in presence of malignancy is high, the result was not conclusive due to the 
small number of patients with malignancy in this  series.(Chart-2.1to5.3) 
Mean age of survivors was 39.78 years (SD ±13.8);  mean age  
among  non-survivors was 53 years (SD ±11.3) considerably younger than 
other studies using MPI in which mean age was 49–66 years old (range 2 
to 93 years). Although our study group excluded pediatric patients, our 
mean age was younger than other series that included children (6,16,26, 
28, 42,43,53). This can be due to difference in population pyramids. 
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Generalized peritonitis with early intervention ie less than 24hrs  
have better prognosis and intervention more than 24hrs and non colonic  
origin has poor prognosis and long duration of hospital stay average  
hospital stay was 12.96 days ranging from 0 to 45 days. (Chart -4) 
Approximately 18.7% were female and 81.3% were male with 
mortality of 18%(5/28)and 15%(18/122) respectively. Noncolonic origin is 
also considered an adverse factor with 95% mortality when compared to 
colonic origin 5% To conclude that MPI is a useful method to determine 
study group outcome in patients with peritonitis surgically evaluated.( 
Chart-5.3) Considering survival related with character of peritoneal fluid 
we found :clear fluid had mortality 2.2% (2/90) ,purulent fluid mortality 
rate of 32.7% (19/58),and fecal fluid had mortality 100%(2/2). 
          To conclude that MPI is a useful method to determine study group 
outcome in patients with peritonitis surgically evaluated. All MPI adverse 
factors, except colonic origin, behaved as expected, and the following  
were especially useful: presence of the organic failure; time elapsed >24 h; 
presence of  malignity; age >50 years, and generalized extension of 
peritonitis. MPI, together with surgeon’s clinical  judgment of each case, 
may be another possible use of this score, aiding the surgeon in making the 
always difficult decision of reintervention in  a patient. 
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CHARTS 
Outcome –Chart1.1 
Outcome Frequency Percent 
Died 23 15.3 
Discharged 110 73.3 
Wound sepsis & 
Discharged 
17 11.3 
Total 150 100 
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Out of 150 patients 23 (15.3%) patients were died. 17 (11.4%) were 
Wound sepsis and Discharged. 110 (73.3%) patients 
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Mannheim Score-Chart1.2 
Mannheim Score Frequency Percent 
<15 72 48.0 
16-25 57 38.0 
>25 21 14.0 
Total 150 100 
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Out of 150 patients, Mannheim score for 72(48%) Patients were <15 
points and 57 (28%) patients was 16-25 points. 21 (14%) patients was >25 
points. 
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Comparison of Mannheim Score and outcome. Chart-1.3 
 
Mannheim Score 
<15 Points 16-25 Points >25 Points 
Died 1 9 13 
Discharged 67 39 4 
Wound sepsis & 
Discharged 4 9 4 
 72 57 21 
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Age Group –Chart 2.1 
Age Group Frequency Percent 
<50 102 68.0 
>50 48 32.0 
Total 150 100.0 
 
Age Group <50 
68% 
Age Group >50 
32% 
Age Group  
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Comparison of Mannheim score and Age group - Chart-2.2 
 Mannheim Score 
<15 Points 16-25 Points >25 Points 
Age  group  <50 62 34 6 
Age  group  >50 10 23 15 
Total 72 57 21 
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Comparison of outcome and Age group Chart -2.3 
 
 
Outcome 
Total 
Died Discharged Wound sepsis & Discharged 
Age Group <50 8  (8%) 83 (81%) 11 (11%) 102 
Age Group >50 15 (31%) 27 (56%) 6 (13%) 48 
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Sex-Chart 3.1 
Sex  Frequency Percent 
Female 28 18.7 
Male 122 81.3 
Total 150 100.0 
 
Female 
19% 
Male 
81% 
Sex  
 
 
Out of 150 patients, 28 were female (18.7%) and 122 (81.3%). 
Group Mean age was 41.8 (+14.25) years with median of 40.00 years. 
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Comparison of sex and outcome Chart-3.2 
 
 
Outcome 
Total 
 Died Discharged Wound sepsis & Discharged 
Female 5 (18%) 19 (68%) 4 (14%) 28 
Male 18 (15%) 91(74%) 13 (11%) 122 
 
0
10
20
30
40
50
60
70
80
Died Discharged Wound sepsis &
Discharged
P
e
r
c
e
n
t
a
g
e
 
Outcome  
Comparison of outcome and sex 
Female Male
 
 
 
 
 
56 
 
Intervention and outcome Chart-4 
 
Day of 
Intervention 
 
Outcome 
Total 
Died Discharged Wound sepsis & Discharged 
< 24 hours 1 (1%) 77 (94%) 4 (5%) 82 
> 24 hours  22 (32%) 33 (49%) 13 (19%) 68 
  23 110 17 150 
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Etiological Chart 5.1 
Diagnosis Frequency Percent 
Duodenal Perforation 83 55.3 
Gastric Perforation 16 10.7 
Appendicular Pathology 15 10.0 
Small bowel 19 12.7 
Large Bowel 7 4.7 
Miscellaneous 10 6.7 
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were evolved without any complications and were discharged from 
the hospital. 
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Comparison of  outcome and Diagnosis –Chart-5.2 
 Died Discharged Wound sepsis & Discharged Total 
Duodenal 
Perforation 7 (8%) 67 (81%) 9 (11%) 83 
Gastric 
Perforation 6 (38%) 7 (44%) 3 (18%) 16 
Appendicular 
Pathology 1 (7%) 12 (80%) 2 (13%) 15 
Small bowel 5 (26%) 13 (68%) 1 (6%) 19 
Large Bowel 2 (29%) 5 (71%) 0 7 
Miscellaneous 2 (20%) 6 (60%) 2 (20%) 10 
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Comparison of risk factor of Mannheim Peritonitis index in three intervals Chart-5.3 
<15 Points  48% (72/150) 16-25 Points 38 % (57/150) >25 Points 14%  (21/150) 
 
Died (1/72) 
1% 
Wound sepsis 
& Discharged 
 
Discharged 
Died 
(9/57) 
16% 
Wound 
sepsis & 
Discharged 
Dis 
charged 
Died 
(13/21) 
76% 
Wound 
sepsis & 
Discharged 
Discharged 
 Patients %  %  %  %  %  %  %  %  % 
Age  Group 
Age 
<50 0 0 4 100 58 86.57 4 44.44 7 77.78 23 58.97 4 30.77 0 0.00 2 50.00 
Age 
>50 1 100 0 0 9 13.43 5 55.56 2 22.22 16 41.03 9 69.23 4 100.00 2 50.00 
Sex 
Female 0 0 0 0 5 7.46 1 
11.
11 2 22.22 
1
1 
28.2
1 4 30.77 2 50.00 13 81.25 
Male 1 100 4 100 62 92.54 8 
88.
89 7 77.78 
2
8 
71.7
9 9 69.23 2 50.00 3 18.75 
60 
Diagnosis 
Non 
Colonic 1 100 4 100 64 96 9 100 9 100 
3
7 95 11 85 4 100 4 100 
Colonic 0 0 0 0 3 4 0 0 0 0 2 5 2 15 0 0 0 0 
Day of Intervention 
< 24 
hours 0 0 3 75 58 
86.
6 1 
11.
1 1 11.1 
1
7 43.6 0 0 0 0 2 50 
> 24 
hours 1 100 1 25 9 
13.
4 8 
88.
9 8 88.9 
2
2 56.4 13 100.0 4 100 2 50 
                   
 
 
 PROFORMA 
 
Name      :  
Age       : 
Sex      : 
Onset of symptoms    : 
Previous Hospitalization    : 
Duration of onset of symptoms  
to Hospital      : 
D.O.A      : 
D.O.D.     :  
Pre OP Diagnosis     : 
Post OP Diagnosis    : 
Treatment      : 
Date of Surgery    : 
Procedure      : 
Duration of Hospital stay   : 
 
Mannheim Peritonitis Index: 
 
 Yes No Score 
Age > 50 Years    
Female Sex    
Organ failure     
Malignancy     
Preoperative 
duration of 
Peritonitis > 24 
Hrs 
   
Origin of sepsis 
not colonic  
   
Diffuse 
generalized 
Peritonitis 
   
Exudate  
Clear 
Cloudy and 
purulent 
Fecal 
   
Total    
Outcome     
i 
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MASTER CHART 
 
S.No 
 
Name Age Sex Day of Intervention 
No. of  days 
stayed in 
Hospital 
Mannheim 
Score Diagnosis Treatment Outcome 
1 Mr.Kumar 28 M 1 9 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
2 Mr.Pradeep 20 M 1 9 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
3 Mr.Chinnappa 50 M 2 31 20 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
4 Mr.Duraiswamy 45 M 1 9 20 Prepyloric  
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
5 Mr.Devaraj 65 M 1 12 15 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
6 Mr.Kuppan 45 M 3  27 Ca.Rectum End colostomy Died 
7 Mr.Sengeni 45 M 1 10 10 Ruptured 
Liver abscess 
Peritoneal lavage  Discharged 
8 Mr.Raja 20 M 3 25 16 Gangrenous 
appendicitis 
Peritoneal lavage Discharged 
9 Mr.Rathinam 65 M 2 25 29 Duodenal 
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
10 Mr.Durai 60 M 1 11 15 Gasrtic 
perforation 
Laparotomy 
perforation closure 
Discharged 
11 Mr.Prasanth 15 M 1 13 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
12 Mrs.Malliga 55 F 1 16 18 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
xvi 
 
S.No 
 
Name Age Sex Day of Intervention 
No. of  days 
stayed in 
Hospital 
Mannheim 
Score Diagnosis Treatment Outcome 
13 Mr.Gangadharan 58 M 2 13 19 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
14 Mr.Saranraj 14 M 1 9 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
15 Mr.Shanmugam 48 M 2 15 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
16 Mr.Ramakrishnan 52 M 1 9 15 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
17 Mr.Dhanamal 70 F 2 31 30 Prepyloric  
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
18 Mr.Settu 40 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
19 Mr.Gunapatham 35 M 2 10 20 Appendicular 
perforation 
Peritoneal lavage & 
appendicectomy 
Discharged 
20 Mr.Kuttiammal 35 F 3 13 26 Ileal gangrene Resection 
anastomosis 
Discharged 
21 Mr.Perumal 47 M 1 9 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
22 Mr.Badrulan 45 M 1 13 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
23 Mr.Arumugam 35 M 3 11 20 Appendicular 
perforation 
Peritoneal lavage 
appendicectomy 
Discharged 
24 Mr.Kathirvel 35 M 4 13 14 Ileal 
perforation 
Laparotomy 
perforation closure 
Discharged 
xvii 
 
S.No 
 
Name Age Sex Day of Intervention 
No. of  days 
stayed in 
Hospital 
Mannheim 
Score Diagnosis Treatment Outcome 
25 Mrs.Kuppammal 40 F 7 11 25 Ileal 
perforation 
Laparotomy 
perforation closure 
Discharged 
26 Mr.Ravi 32 M 1 10 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
27 Mrs.Chokkammal 63 F 7 16 30 Ileal 
perforation 
Laparotomy 
perforation closure 
Discharged 
28 Mr.Subramani 40 M 3 12 20 Gangrenous 
appendicitis 
Peritoneal lavage & 
appendicectomy 
Discharged 
29 Mr.Manivannan 29 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
30 Mr.Elumalai 52 M 1 10 15 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
31 Mr.Mohanraj 25 M 3 15 20 Appendicular 
perforation 
Peritoneal lavage & 
appendicectomy 
Wound sepsis 
& Discharged 
32 Mr.Veerappan 40 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
33 Mr.Rajesh 17 M 1 9 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
34 Mr.Karthikeyan 40 M 2 15 16 Appendicular 
perforation 
Peritoneal lavage & 
appendicectomy 
Discharged 
35 Mr.Sridhar 55 M 2 12 19 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
36 Mr.Muniyan 32 M 1 8 16 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
xviii 
 
S.No 
 
Name Age Sex Day of Intervention 
No. of  days 
stayed in 
Hospital 
Mannheim 
Score Diagnosis Treatment Outcome 
37 Mr.Mani 49 M 1 10 8 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
38 Mrs.Latha 48 F 1 9 15 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
39 Mr.Vaithi 60 M 1 10 9 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
40 Mr.Valliammal 60 F 3  30 Gasrtic 
perforation 
Laparotomy 
perforation closure 
Died 
41 Mr.Arul Balan 43 M 5 20 20 Ruptured 
Liver abscess 
Peritoneal lavage Discharged 
42 Mr.Elumalai 50 M 3  32 Ileal gangrene Ileostomy Died 
43 Mr.Vasu 64 M 4  25 Prepyloric  
perforation 
Laparotomy 
perforation closure 
Died 
44 Mr.Baskaran 35 M 3 10 14 Appendicular 
perforation 
Peritoneal lavage & 
appendicectomy 
Discharged 
45 Mr.Valliammal 60 F 2 10 24 Ileal 
perforation 
Laparotomy 
perforation closure 
Discharged 
46 Mrs.Rani 35 F 1 14 15 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
47 Mr.Ponnurangam 62 M 3  25 Duodenal 
perforation 
Laparotomy 
perforation closure 
Died 
48 Mr.Loganathan 40 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
49 Mr.Ramamoorthy 35 M 2 28 10 Sigmoid 
volvulus 
Laparotomy  
resection colostomy 
Discharged 
xix 
 
S.No 
 
Name Age Sex Day of Intervention 
No. of  days 
stayed in 
Hospital 
Mannheim 
Score Diagnosis Treatment Outcome 
50 Mr.Ravi 40 M 2 19 10 Sigmoid 
volvulus 
Laparotomy resection 
colostomy 
Discharged 
51 Mr.Balaji 30 M 1 10 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
52 Mr.Ravi 20 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
53 Mr.Parasuramman 42 M 1 14 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
54 Mr.Karthik 18 M 1 5 16 Appendicular 
perforation 
Peritoneal lavage & 
appendicectomy 
Discharged 
55 Mr.Ellappan 40 M 3  20 Prepyloric  
perforation 
Laparotomy 
perforation closure 
Died 
56 Mr.Perumal 22 M 1 11 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
57 Mr.Kulluchami 59 M 1 37 13  RTA blunt 
injury 
abdomen 
pelvic fracture 
Laparotomy  bladder 
injury repair 
Discharged 
58 Mr.Subrayan 25 M 1 12 15 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
59 Mr.Dharman 32 M 3 10 20 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
60 Mr.Sugumar 25 M 1 10 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
xx 
 
S.No 
 
Name Age Sex Day of Intervention 
No. of  days 
stayed in 
Hospital 
Mannheim 
Score Diagnosis Treatment Outcome 
61 Mr.Mani 42 M 1 8 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
62 Mr.Umapathy 60 M 3 12 25 Ruptured 
Liver abscess 
Peritoneal lavage Discharged 
63 Mr.Hari 34 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
64 Mr.Muthuvel 35 M 2 17 19 Antral 
perforation 
Laparotomy 
perforation closure 
Discharged 
65 Mr.Durai 40 M 1 12 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
66 Mr.Selvam 40 M 1 13 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
67 Mr.Elumalai 16 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
68 Mr.Senu 35 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
69 Mr.Shaikali 45 M 7 24 20 Ruptured 
Liver abscess 
Peritoneal lavage Wound sepsis 
& Discharged 
70 Mrs.Amirthammal 45 F 3 14 19 Sigmoid 
volvulus 
Resection 
anastomosis 
Discharged 
71 Mr.Moorthy 42 M 1 20 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
72 Mrs.Venda 42 F 1 12 9 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
xxi 
 
S.No 
 
Name Age Sex Day of Intervention 
No. of  days 
stayed in 
Hospital 
Mannheim 
Score Diagnosis Treatment Outcome 
73 Mr.Munuswamy 56 M 3 15 25 Prepyloric  
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
74 Mr.Bakiya 45 F 2 15 25 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
75 Mr.Arumugam 45 M 5 26 20 Duodenal 
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
76 Mr.Krishnan 19 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
77 Mr.Devaraj 44 M 1 15 16 Prepyloric  
perforation 
Laparotomy 
perforation closure 
Discharged 
78 Mr.Ramesh 33 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
79 Mr.Munuswamy 65 M 5 15 25 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
80 Mr.Devaraj 30 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
81 Mr.Ramadass 50 M 2 13 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
82 Mrs.Alamelu 60 F 7  30 Ruptured 
Liver abscess 
Peritoneal lavage Died 
83 Mr.Arumugam 30 M 2 17 20 Duodenal 
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
84 Mr.Kanniappan 47 M 1 12 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
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85 Mr.Logannathan 40 M 2 15 20 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
86 Mr.Gurunathan 50 M 2 11 19 Prepyloric  
perforation 
Laparotomy 
perforation closure 
Discharged 
87 Mr.Narayanan 40 M 1 12 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
88 Mr.Chandran 35 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
89 Mrs.Devi 28 F 1 12 9 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
90 Mr.Venugopal 65 M 1 13 19 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
91 Mr.Vasu 60 M 4 13 21 Ileal gangrene Resection 
anastomosis 
Discharged 
92 Mr.Elumalai 60 M 1 14 25 Ileal gangrene Resection 
anastomosis 
Discharged 
93 Mrs.Valliammal 78 F 7 21 30 Duodenal 
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
94 Mr.Balu 50 M 1 10 19 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
95 Mr.Ravichandran 70 M 3  25 Duodenal 
perforation 
Laparotomy 
perforation closure 
Died 
96 Mr.Pandiyan 52 M 1 11 19 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
97 Mrs.Meenatchi 57 F 1 14 21 Ileal gangrene Resection Discharged 
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anastomosis 
98 Mr.Srinivasan 50 M 2  25 Gasrtic 
perforation 
Laparotomy 
perforation closure 
Died 
99 Mr.Perumal 53 M 5  31 Ileal 
perforation 
Laparotomy 
perforation closure 
Died 
100 Mrs.Lalitha 45 F 1 13 26 Small bowel 
adhesion & 
banding 
Laparotomy resection 
anastomosis 
Discharged 
101 Mr.Munuswamy 65 M 3  30 Gasrtic 
perforation 
Laparotomy 
perforation closure 
Died 
102 Mr.Raja 24 M 1 11 14 Appendicular 
perforation 
Laparotomy & 
Appendicectomy 
Discharged 
103 Mr.Pattabi 40 M 3 18 20 Duodenal 
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
104 Mr.Selvam 30 M 7 35 14 Sigmoid 
volvulus 
Resection 
anastomosis 
Discharged 
105 Mr.Muniyandi 22 M 1 9 10 Meckeles 
diverticulum 
adhesion 
Resection 
anastomosis 
Discharged 
106 Mrs.Majeema 27 F 1 11 19 Torsion 
ovarian cyst L 
Laparotomy R 
Oopherectomy 
Discharged 
107 Mr.Arumugam 60 M 3  32 Small bowel 
gangrene 
Hemicolectomy 
Ileostomy 
Died 
108 Mr.Palani 45 M 2  27 Gasrtic 
perforation 
Laparotomy 
perforation closure 
Died 
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109 Mr.Mani 52 M 3  14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Died 
110 Mr.Sathish 18 M 3 15 14 Meckeles 
diverticulum 
adhesion 
Laparotomy resection 
anastomosis 
Discharged 
111 Mr.Durai 40 M 1 11 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
112 Mr.Chinnapayan 45 M 3 15 10 Intussuception Resection 
anastomosis 
Discharged 
113 Mr.Balaraman 65 M 3  25 Duodenal 
perforation 
Laparotomy 
perforation closure 
Died 
114 Mr.Rajasekar 19 M 1 11 16 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
115 Mr.Ganesan 40 M 1 13 20 Ruptured 
Liver abscess 
Peritoneal lavage Discharged 
116 Mrs.Oonchiammal 60 F 2 31 24 Duodenal 
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
117 Mrs.Saritha 29 F 1 12 15 Gangrenous 
appendicitis 
Peritoneal lavage & 
appendicectomy 
Discharged 
118 Mr.Vinodkumar 38 M 1 11 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
119 Mr.Narayanasamy 55 M 3  32 Ileal gangrene Resection 
&Jejunostomy 
cecostomy 
Died 
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120 Mr.Raja 22 M 1 10 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
121 Mr.Shanmugam 71 M 4  32 Duodenal 
perforation 
Laparotomy 
perforation closure 
Died 
122 Mrs.Elavarasi 40 F 1  25 Gangrenous 
appendicitis 
Peritoneal lavage Died 
123 Mrs.Minnalu 35 F 5 11 25 Appendicular 
abscess 
Peritoneal lavage Discharged 
124 Mr.Subramani 46 M 1 13 20 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
125 Mrs.Shanthi 48 F 2 35 25 Duodenal 
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
126 Mr.Vijayakumar 22 M 1 15 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
127 Mr.Gnanavel 26 M 1 16 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
128 Mrs.Anjalai 39 F 2  36 Hollow viscus 
perforation 
with ca cervix 
B/L flank drain Died 
129 Mrs.Poonghauli 29 F 4  31 Ceacal 
volvulus 
R Hemicolectomy 
end to end 
anastomosis 
Died 
130 Mr.Raji 50 M 1 11 15 Prepyloric  
perforation 
Laparotomy 
perforation closure 
Discharged 
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131 Mr.Dharmaraj 15 M 1 16 14 Appendicular 
perforation 
Peritoneal lavage & 
appendicectomy 
Wound sepsis 
& Discharged 
132 Mr.Chandra 
Sathiya 
37 M 1 12 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
133 Mr.Sridhar 34 M 1 11 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
134 Mr.Koteeswari 30 F 1 25 23 Transverse 
colon 
gangrene 
R Hemicolectomy 
end to end 
anastomosis 
Discharged 
135 Mr.Gopal 60 M 5  31 Duodenal 
perforation 
Laparotomy 
perforation closure 
Died 
136 Mr.Murugesan 30 M 1 18 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
137 Mrs.Muniammal 30 F 1 15 19 Prepyloric  
perforation 
Laparotomy 
perforation closure 
Discharged 
138 Mr.Karthikeyan 34 M 1 9 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
139 Mr.Senthilkumar 30 M 1 12 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
140 Mr.Adhikesavan 30 M 2 14 20 Gangrenous 
appendicitis 
Peritoneal lavage Discharged 
141 Mrs.Egavalli 50 F 1 15 25 Appendicular 
perforation 
Peritoneal lavage & 
appendicectomy 
Discharged 
142 Mr.Madhavan 44 M 3  23 Ruptured 
Liver abscess 
Peritoneal lavage Died 
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143 Mr.Saranraj 19 M 1 11 10 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
144 Mr.Murugesan 50 M 3 45 32 Ileal gangrene Resection 
anastomosis 
Wound sepsis 
& Discharged 
145 Mr.Arumugam 40 M 3  19 Duodenal 
perforation 
Laparotomy 
perforation closure 
Died 
146 Mr.Jeeva 20 M 1 43 10 Stab injury  R Hemicolectomy 
end to end 
anastomosis 
Wound sepsis 
& Discharged 
147 Mr.Veeraragavan 50 M 1 38 32  Internal 
hernia & 
Banding  with 
adhesion 
Resection 
anastomosis 
Discharged 
148 Mr.Arumugam 60 M 1 12 19 Gasrtic 
perforation 
Laparotomy 
perforation closure 
Discharged 
149 Mr.Annappan 55 M 1 11 15 Duodenal 
perforation 
Laparotomy 
perforation closure 
Discharged 
150 Mr.Govindaswamy 32 M 2 18 14 Duodenal 
perforation 
Laparotomy 
perforation closure 
Wound sepsis 
& Discharged 
 
 
 
